Neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease,
Huntington's disease and amyotrophic lateral sclerosis, are a group of incurable …

Short-term symptomatic treatment and dose-dependent side effects of pharmacological
treatment for neurodegenerative diseases have forced the medical community to seek an …

Neurologic complications are commonly regarded as irreversible impairments that stem from
limited potential of regeneration of the central nervous system (CNS). On the other side, the …

Stem cell therapies have been proposed as a treatment option for neurodegenerative
diseases, but the best stem cell source and therapeutic efficacy for neuroregeneration …

Parkinson's disease (PD) has become the second largest neurodegenerative disease after
Alzheimer's disease, and its incidence is increasing year by year. Traditional dopamine …

Neurodegenerative disease refers to any pathological condition in which there is a
progressive decline in neuronal function resulting from brain atrophy. Despite the immense …

As the most common form of dementia and a progressive neurodegenerative disorder,
Alzheimer's disease (AD) affects over 10% world population with age 65 and older. The …

Neurodegenerative disorders are one of the leading causes of death and disability and one
of the biggest burdens on health care systems. Novel approaches using various types of …

Alzheimer's disease (AD) is the most common type of dementia affecting regions of the
central nervous system that exhibit synaptic plasticity and are involved in higher brain …

Parkinson's disease (PD) is a chronic, progressive, neurodegenerative disease. The
predominant pathology of PD is the loss of dopaminergic cells in the substantia nigra. Cell …